tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market

Annexon Biosciences (ANNX) Income Statement

644 Followers

Annexon Biosciences Income Statement

Last quarter (Q4 2023), Annexon Biosciences's total revenue was $400.00K, a decrease of -50.00% from the same quarter last year. In Q4, Annexon Biosciences's net income was $-27.89M. See Annexon Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.00M$ 2.00M$ 1.60M$ 100.00K$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 2.00M$ 2.00M$ 1.60M$ 100.00K--
Operating Expense
$ 143.72M$ 143.72M$ 145.60M$ 130.71M$ 63.47M$ 32.52M
Operating Income
$ -143.72M$ -143.72M$ -145.60M$ -130.71M$ -63.47M$ -32.52M
Net Non Operating Interest Income Expense
----$ 57.00K-
Other Income Expense
----$ 57.00K$ -4.66M
Pretax Income
$ -143.72M$ -143.72M$ -145.60M$ -130.71M$ -63.41M$ -37.18M
Tax Provision
--$ 135.00K$ -133.00K$ 0.00$ 4.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -134.24M$ -134.24M$ -141.95M$ -130.32M$ -70.34M$ -38.28M
Basic EPS
$ -1.78$ -1.77$ -2.60$ -3.40$ -4.15$ -2.75
Diluted EPS
$ -1.78$ -1.77$ -2.60$ -3.40$ -4.15$ -2.75
Basic Average Shares
$ 302.69M$ 75.67M$ 54.67M$ 38.32M$ 16.96M$ 11.45M
Diluted Average Shares
$ 302.69M$ 75.67M$ 54.67M$ 38.32M$ 16.96M$ 11.45M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 143.72M$ 143.72M$ -145.60M$ 130.71M$ 63.47M$ 32.52M
Net Income From Continuing And Discontinued Operation
$ -134.24M$ -134.24M$ -141.95M$ -130.32M$ -63.41M$ -37.18M
Normalized Income
$ -80.96M$ -113.54M--$ -63.41M$ -37.18M
Interest Expense
------
EBIT
$ -143.72M$ -143.72M$ -145.60M$ -130.71M$ -63.47M$ -32.52M
EBITDA
$ -63.99M$ -143.01M$ -142.22M$ -126.05M$ -62.80M$ -32.02M
Currency in USD

Annexon Biosciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis